Affiliation: The Children's Memorial Health Institute
- The impact of infliximab induction therapy on mucosal healing and clinical remission in Polish pediatric patients with moderate-to-severe Crohn's diseaseJarosław Kierkuś
Department of Gastroenterology, Hepatology and Immunology, Children s Memorial Health Institute, Warsaw, Poland
Eur J Gastroenterol Hepatol 24:495-500. 2012..To assess the clinical efficacy and the impact of infliximab (IFX) induction therapy on mucosal healing in Polish children with Crohn's disease (CD)...
- [Influence of inflammatory bowel disease on pregnancy and fertility - optimal treatment and management]Jarosław Kierkuś
Klinika Gastroenterologii, Hepatologii i Zaburzeń Odżywiania, Instytut Pomnik Centrum Zdrowia Dziecka, Warszawa
Med Wieku Rozwoj 17:77-84. 2013....
- [Efficacy and safety of cyclosporine in the treatment of inflammatory bowel disease in children - a retrospective study]Piotr Socha
Klinika Gastroenterologii, Hepatologii i Immunologii, Instytut Pomnik Centrum Zdrowia Dziecka, Al Dzieci Polskich 20, 03 740 Warszawa, Poland
Med Wieku Rozwoj 10:429-35. 2006..the aim of this study was to report single centre experience with cyclosporine used in treatment of children with inflammatory bowel disease with regard to safety and efficacy...
- Monotherapy with infliximab versus combination therapy in the maintenance of clinical remission in children with moderate to severe crohn diseaseJarosław Kierkuś
Children s Memorial Health Institute, Warsaw Department of Pediatrics, Gastroenterology and Nutrition, Medical University of Wroclaw Department of Paediatrics, Medical University of Silesia, Gastroenterology Unit, Upper Silesian Child Health Care Centre, Katowice Department of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw Wl Buszkowski Kielce Province Children s Hospital, Kielce Department of Paediatric Allergology, Gastroenterology and Nutrition, Medical University of Lodz Paediatric Nursery Unit of Pomeranian Medical University, Division of Paediatrics, Gastroenterology and Rheumatology of Zdroje Hospital in Szczecin Department of Pediatrics, Allergology and Gastroenterology, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun Department of Pediatrics, Gastroenterology and Nutrition Jagiellonian University School of Medicine, Cracow, Poland
J Pediatr Gastroenterol Nutr 60:580-5. 2015....
- Gene conversion between cationic trypsinogen (PRSS1) and the pseudogene trypsinogen 6 (PRSS3P2) in patients with chronic pancreatitisAgnieszka Magdalena Rygiel
Department of Medical Genetics, Institute of Mother and Child Warsaw, Warsaw, Poland
Hum Mutat 36:350-6. 2015..The pathogenic phenotype of the novel conversion is explained by a unique combination of increased trypsinogen activation and secretion. ..